Support Burnet’s COVID-19 emergency response
COVID-19 represents an unprecedented health, social and economic challenge in Australia and around the world. Support Burnet’s COVID-19 emergency response today.
COVID-19 represents an unprecedented health, social and economic challenge in Australia and around the world. Support Burnet’s COVID-19 emergency response today.
We have commenced a large project to express both spike and nucleoprotein of COVID-19, and other coronaviruses - SARS, MERS, OC43, 229E, NL63, and HKU1.
The antigens will be provided to Burnet’s Global Health Diagnostics Development Group for development of a COVID-19 point-of-care (PoC) diagnostic.
Our lab will contribute to PoC test development by providing novel technology to alter antigen structure and enhance sensitivity of PoC tests that can be monitored by Biolayer interferometry.
The Viral Entry and Vaccines Group have extensive expertise in the expression of viral glycoprotein antigens, manipulation of protein sequences to enhance expression and alter folding characteristics and optimisation of purification methods to increase yield and purity.
2020 -
Victorian Government (part of $1m for Diagnostics Development)
For any general enquiries relating to this project, please contact:
Program Director, Disease Elimination; Co-Head, Drummer/Poumbourios Laboratory
To achieve better health for vulnerable communities in Australia and internationally by accelerating the translation of research, discovery and evidence into sustainable health solutions.
85 Commercial Road, Melbourne
VIC, 3004, Australia
Receive updates and IMPACT magazine.
Copyright © 2020 Burnet Institute. ABN: 49 007 349 984
This website was developed with the generous support of a donor.
Burnet Institute (Australia) is located on the traditional land of the Boon Wurrung and Wurundjeri people and we offer our respects to the elders past and present.
We recognise and respect the cultural heritage of this land.
